TMUS three-lens brief
Evidence-based stock research on TMUS. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -2.20% yesterday. · Trading at 11% of its 52-week range — deep in the lower band.
- Moved -2.20% yesterday.
- Trading at 11% of its 52-week range — deep in the lower band.
- Underperforming SPY by 18.6pp over 30 days.
- Analyst mean target $268.35 — 41% above current (26 analysts).
- Debt-to-equity of 208.9 — balance-sheet-heavy.
TMUS closed at $189.80 (-2.20%) as of 2026-04-25. Market cap: $209.13B. P/E (trailing) 19.5. Positives: analyst mean target $268.35 — 41% above current (26 analysts).. Concerns: moved -2.20% yesterday.; trading at 11% of its 52-week range — deep in the lower band.. Last quarter: Revenue $24.33B, net income $2.10B, free cash flow $8.00B.
Why three lenses on TMUS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine TMUSacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/TMUS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath TMUS brief"></iframe>